Channels

REGN

The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Thursday's prices. Each symbol is a hyperlink or shortcut to more information.

REGN 2.85%


Profile NASDAQ: REGN $38 Billion Large-Cap. Show More

REGN Profile

Market Cap 38 Billion
REGN Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.


Visit Website

REGN Earnings

EPS 6.12 P/E Ratio 24.20
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (10 days ago) Price +8.79%

REGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

REGN Charts

$271.37
1 Year
$442.00
Sep 27, 2019
Mar 4, 2019






Symbol Price Day Ξ” YTD Ξ”
REGN $338.39 -2.85% -9.14%

Channels

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com





    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy